Musculoskeletal

Forteo

TERIPARATIDE (rDNA) Forteo®

TERIPARATIDE (rDNA) Forteo is indicated in adults. It is for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. In postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. Treatment of osteoporosis associated with sustained  systemic glucocorticoid therapy in women and men at increased risk for fracture
Reference: Forteo prescribing information: PA005FSHK02 show more

Top
TGlsbHkwMS0wNjIwMTY=